» Articles » PMID: 2930721

Spontaneous Programmed Death (apoptosis) of B-chronic Lymphocytic Leukaemia Cells Following Their Culture in Vitro

Overview
Journal Br J Haematol
Specialty Hematology
Date 1989 Mar 1
PMID 2930721
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

When B-chronic lymphocytic leukaemia (B-CLL) cells derived from peripheral blood were cultured in vitro, a substantial proportion of them spontaneously died by apoptosis. This type of cell death is morphologically and biochemically distinct from necrosis and has previously been found to occur under physiologic and certain pathologic conditions where cell deletion appears controlled and biologically meaningful. By 30 h of culture, approximately 20% of the unfractionated B-CLL cells were affected. There was no significant difference in the incidence of apoptosis in T-cell depleted and undepleted cultures or when either autologous or normal human serum was used. Furthermore, seeding densities of 2 x 10(6) and 5 x 10(5) cells/ml resulted in a similar incidence of apoptosis, indicating that cell density was unlikely to be a contributing factor in producing the death. The finding that B-CLL cells spontaneously die in vitro has at least two important implications. Firstly, previous work relating to some of the functions of B-CLL cells and their interactions with T cells may require re-evaluation. Secondly, an understanding of the mechanisms involved in the induction of apoptosis in this disease may have therapeutic consequences.

Citing Articles

Potential New Therapies "ROS-Based" in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis.

Sciaccotta R, Gangemi S, Penna G, Giordano L, Pioggia G, Allegra A Antioxidants (Basel). 2024; 13(4).

PMID: 38671922 PMC: 11047475. DOI: 10.3390/antiox13040475.


Chronic Lymphocytic Leukemia: Disease Biology.

Koehrer S, Burger J Acta Haematol. 2023; 147(1):8-21.

PMID: 37717577 PMC: 11753505. DOI: 10.1159/000533610.


Comparing the value of mono- vs coculture for high-throughput compound screening in hematological malignancies.

Herbst S, Kim V, Roider T, Schitter E, Bruch P, Liebers N Blood Adv. 2023; 7(19):5925-5936.

PMID: 37352275 PMC: 10558604. DOI: 10.1182/bloodadvances.2022009652.


Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia.

Pagano G, Fernandez Botana I, Wierz M, Roessner P, Ioannou N, Zhou X Haematologica. 2023; 108(11):3011-3024.

PMID: 37345470 PMC: 10620579. DOI: 10.3324/haematol.2022.282474.


Extracellular Vesicles in Chronic Lymphocytic Leukemia: Tumor Microenvironment Messengers as a Basis for New Targeted Therapies?.

Dubois K, Tannoury M, Bauvois B, Susin S, Garnier D Cancers (Basel). 2023; 15(8).

PMID: 37190234 PMC: 10137283. DOI: 10.3390/cancers15082307.